Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

Market Cap	4.64B -2.9%
Revenue (ttm)	597.21M -6.2%
Net Income	222.82M -24.1%
EPS	2.77 -23.9%
Shares Out	80.72M
PE Ratio	20.77
Forward PE	11.62
Dividend	1.37 (2.36%)
Ex-Dividend Date	Jul 9, 2025

Volume	464,490
Average Volume	431,480
Open	57.99
Previous Close	57.70
Day's Range	57.64 - 58.26
52-Week Range	55.01 - 88.96
Beta	0.38
RSI	35.21
Earnings Date	Apr 23, 2026

About Hangzhou AGS MedTech

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; and EMR products comprising polypectomy snares and disposable sclerotherapy needles. It also provides ESD products, which include electrosurgical generat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 856
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688581

Financial Performance

In 2025, Hangzhou AGS MedTech's revenue was 597.21 million, a decrease of -6.19% compared to the previous year's 636.63 million. Earnings were 222.82 million, a decrease of -24.06%.